Eaton Vance Management Genprex, Inc. Transaction History

Eaton Vance Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.82 - $3.5 $9 - $17	-5 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.21 - $2.7 $147 - $329	-122 Reduced 96.06%	5 $0
Q3 2021 Nov 15, 2021	BUY	$2.59 - $3.36 $51 - $67	20 Added 18.69%	127 $0
Q2 2021 Aug 16, 2021	BUY	$3.11 - $4.87 $332 - $521	107 New	107 $0

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.